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An improved method for detection of pyrazinamide resistance
in Mycobacterium tuberculosisThe poor growth of Mycobacterium tuberculosis in an acidic
mediummeans that culture-based methods for pyrazinamide
susceptibility testing can be difficult to standardise [1]. A re-
cent paper highlighted the limitation of the reference radio-
metric liquid culture system Bactec 460TB standardise
method in detecting pyrazinamide resistance in patients in-
fected with the W-Beijing strains of M. tuberculosis [2]. Newer
automated systems, for example MGIT 960, have not yet
proved to be reliable for this purpose [3]. This leaves the
non-culture-based methods as an alternative to conventional
susceptibility testing methods. Genotypic testing is not suit-
able for routine use due to the wide diversity of mutations
in the pncA associated with resistance [4]. The biochemical
‘‘Wayne assay’’ was suggested as an alternative for detecting
resistance to pyrazinamide resistance based on the detection
of the presence of nicotinamidase enzymatic activity, which
converts the drug into its coloured metabolite pyrazinoic acid
in susceptible strains [5]. The Wayne assay is simple, rapid to
perform and a cost-effective method that has been shown to
correlate well with pyrazinamide resistance in several reports
[5,6]. In a recent study by Sheen, et al., the level of pyrazina-
mide resistance was significantly associated with pyrazinam-
idase activity and efficiency [7]. Sensitivity and specificity of
the Wayne method yet need further improvement. Our group
reported a sensitivity of 79% previously when using the
Wayne assay to identify pyrazinamide resistance in M. tuber-Fig. 1 – (a) The pyrazinamidase assay performed on a 6-well pla
pyrazinamidase agar. The three wells in the upper row demonst
addition of Ferrous ammonium sulphate and the lower row illus
The 6-well plates were sealed and placed in a safety box to avo
tuberculosis on pyrazinamidase agar.culosis clinical isolates [4]. Prolonged incubation for 10 days
has been proposed to improve the reliability of the assay
further [8].
The pyrazinamidase activity test was originally described
as a taxonomic tool to differentiate between M. tuberculosis
and Mycobacterium bovis and is still used in some laboratories
for this purpose [5]. The assay is usually performed in screw-
capped glass universal tubes, and a major factor influencing
the sensitivity of the assay is the difficulty in detecting the
faint pink product on the slope through the glass, thus mak-
ing it hard to interpret the result. We have modified the for-
mat of the Clinical Laboratory Standards Institute method
by carrying out the assay in a six-well plate format (Fig. 1a)
[9], and compared the assay performed in screw-capped glass
universals and into six-well plates (Nunc, Denmark). This
modification was found to aid the reading without indetermi-
nate results in comparison with the standard universal tubes.
This revised method, applied to on 2M. bovis BCG, 18M. tuber-
culosis clinical strains and in a series of laboratory-generated
resistant mutants, provided a simple, reliable technique
which in our hands correlated with pncA sequencing data.
The sealed multi-well plate format assay exposes a large sur-
face area for visualisation which allows detection of minimal
colour change and improves the sensitivity of the assay. This
modification of the Wayne assay might serve as a useful tool,
particularly in resource-limited settings.te, each well contains a particular strain or control grown on
rate positive reactions as a faint pink colour developed upon
trates negative enzymatic activity with no colour change. (b)
id accidental spillage of the semisolid cultures of M.
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cultures of M. tuberculosis and the laboratory personnel are at
risk of acquiring tuberculosis [10]. In order to avoid spillage,
microtiter plates were sealed with multiple layers of parafilm
and then placed inside a lockable safety box (Thermo Fisher
Scientific, Denmark) (Fig. 1b), which was opened only inside
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